Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1

Status

Not yet recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Head & Neck 2Sarcoma 1

Conditions

Thyroid Diseases 1Sarcoma, Alveolar Soft Part 1Polycystic Ovary Syndrome 1Infertility, Female 1Advanced Differentiated Thyroid Gland Carcinoma 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Thyroxine × 1 year × Clear all
NCT06790589 2026-02-06

COACH - Comparing Two Different Methods to Suppress Thyrotropin in Patients With Advanced Thyroid Cancer

AHS Cancer Control Alberta

Phase 2 Not yet recruiting
70 enrolled
Head & Neck

Advanced Differentiated Thyroid Gland Carcinoma

NCT01391962 2026-02-02

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
34 enrolled 22 charts
Sarcoma

Sarcoma, Alveolar Soft Part

NCT07239674 2025-11-20

DELTA

West China Hospital

Phase 3 Not yet recruiting
646 enrolled
Head & Neck

Thyroid Diseases

NCT06041204 2025-09-03

Best Treatment for Women With Both (Polycystic Ovary Syndrome) PCOS and Subclinical Hypothyroidism

Al-Azhar University

Phase NA Recruiting
200 enrolled

Infertility, Female, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡